Skip directly to search
Skip directly to A to Z list
Skip directly to navigation
Skip directly to page options
Skip directly to site content
Start of Search Controls
Search Form Controls
Search The CDC
submit
CDC A-Z Index
MENU
CDC A-Z
SEARCH
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Search Form Controls
Search The CDC
submit
CDC A-Z Index
Public Health Genomics and Precision Health Knowledge Base (v10.0)
PHGKB
About
Public Health Genomics Branch
PHGKB Weekly Horizon Scan
Genomics Precision Health Scan
Advanced Molecular Detection Clips
Non-Genomics Precision Health Scan
CDC-authored Publications Scan
Specialized PHGKB
Cancer PHGKB
Diabetes PHGKB
Economic Evaluation PHGKB
Environmental Health PHGKB
Family Health History PHGKB
Health Equity PHGKB
HLBS-PopOmics
Infectious Diseases PHGKB
Implementation Science PHGKB
Neurological Disorders PHGKB
Pharmacogenomics PHGKB
Primary Immune Deficiency Diseases PHGKB
Rare Diseases PHGKB
Reproductive and Child Health PHGKB
All Databases
COVID-19 GPH (50297)
CDC/NIH Web Information Database (32266)
CDC-Authored Genomics and Precision Health Publications Database (6432)
Precision Health Database (64289)
Pathogen Advanced Molecular Detection Database (28063)
All of Us Reports and Publications Database (1203)
Human Genome Epidemiology
Human Genome Epidemiology Literature Finder (234082)
Epigenetic Epidemiology Publications Database (24098)
Release Note
Contact Us
CDC/NIH Web Information Database|Home|Public Health Genomics and Precision Health Knowledge Base (PHGKB)
CDC/NIH Web Information Database
CDC/NIH Information Database|Search|PHGKB
Cancer
Last data update: Dec 02, 2024
. (Total: 8777 Documents)
All
Cancer
Diabetes
Economic
Equity
Environmental
FHH
HLBS
ID
Implementation
ND
PGx
PI
Rare
RCH
dataset
All
CDC
NIH
Records 1-20 (of 20 Records)
CDC/NIH Web Information
Leveraging Artificial Intelligence to Improve Accuracy of Lung Cancer Screening
NCI Blog, December 16, 2022
Lung Adenocarcinoma (LUAD) Discoveries from two NCI Proteomics Consortia
NCI, July 9, 2020
Study Suggests Repurposed Drugs Might Treat Aggressive Lung Cancer
NIH Director's Blog, November 19, 2019
Atezolizumab Approved for Initial Treatment of Metastatic Lung Cancer
NCI, January 2019
For Early-Stage Lung Cancer, Study Identifies Potential New Biomarker, Treatment Target
NCI, January 3, 2019
Most cases of lung cancer are due to smoking; however, there are other risk factors including family history.
Two-Drug Combination Approved for Lung Cancers with BRAF Mutations
NCI, July 18, 2017
Noninvasive strategies for lung cancer testing
NIH Research Matters, March 7, 2017
With FDA Approval, Gefitinib Returns to U.S. Market for Some Patients with Lung Cancer
Approval of Osimertinib and Necitumumab Increases Lung Cancer Treatment Options
Using Gene Expression to Diagnose Lung Cancer More Accurately
Bringing Precision to Screening for Cancer
FDA Approves Alectinib for ALK-Positive Non-Small Cell Lung Cancer
Targeted Photoimmunotherapy Approach for Cancer Moves Forward
Enhanced Risk-Based Lung Cancer Screening May Prevent More Deaths than Current Approaches
Asbestos-Related Lung Diseases
From NHLBI health topic site
Idiopathic Pulmonary Fibrosis
From NHLBI health topic site
Non-small cell lung cancer, childhood
From NCATS Genetic and Rare Diseases Information Center
Small cell lung cancer, adult
From NCATS Genetic and Rare Diseases Information Center
Small cell lung cancer, childhood
From NCATS Genetic and Rare Diseases Information Center
File Formats Help:
How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?
Adobe PDF file
Microsoft PowerPoint file
Microsoft Word file
Microsoft Excel file
Audio/Video file
Apple Quicktime file
RealPlayer file
Text file
Zip Archive file
SAS file
ePub file
Page last reviewed:
Feb 1, 2024
Content source:
Public Health Genomics Branch in the Division of Blood Disorders and Public Health Genomics
,
National Center on Birth Defects and Developmental Disabilities
TOP